Stay updated with breaking news from Red Cell Revolution. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
– Both Mitapivat Dose Arms Achieved Statistically Significant Hemoglobin Response in Phase 2 Portion of RISE UP Pivotal Study in Sickle Cell Disease, Compared to the Placebo Arm; Data Support
28.02.2023 - Red Blood Cell Advisory Council Unites Patients, Caregivers and Physicians Across Pyruvate Kinase (PK) Deficiency, Thalassemia and Sickle Cell Disease to Generate Cross-indication Solutions, Support and AwarenessCAMBRIDGE, Mass., Feb. 28, 2023 ... Seite 1